CAS:1197-18-8
Другие названия: Транексамовая кислота
MF: C8H15NO2, C8H15NO2
EINECS No.:214-818-2
Synonyms: TIMTEC-BB SBB006715; TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID; trans-4-aminomethylcyclohexane-1-carboxylate
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
CAS:1197-18-8
Другие названия: Транексамовая кислота
MF: C8H15NO2, C8H15NO2
EINECS No.:214-818-2
Synonyms: TIMTEC-BB SBB006715; TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID; trans-4-aminomethylcyclohexane-1-carboxylate
Tranexamic Acid with CAS 1197-18-8 is a synthetic derivative of lysine. It is a commonly used hemostatic agent in clinical practice. It plays a hemostatic effect by inhibiting the dissolution of fibrin. Trantranic acid can strongly adsorb Lysine-binding sites of fibrinogen affinity sites on plasminase and plasminogen, and inhibit the binding of plasminogen and fibrin, and thus strongly inhibit the decomposition of fibrin caused by plasminogen. In addition, the antifibrinolytic effect of tranatemic acid was more obvious in the presence of antifibrinolytic enzymes such as macroglobulin in serum
Товары из Тест | Стандартный as per USP30 |
Описание |
1.White crystalline powder,Odorless and has a bitter taste |
2.Freely soluble in water and glacial Acetic acid; very slightly soluble in ethanol; practically insoluble in Ether | |
3.dissolves in sodium hydroxide TS | |
Идентификация |
1.Nimhydrin reaction produces a Deep purple colour |
2.the dried precipitate formed with
p-toluenesulfonic acid melts between 265.0℃-266.0℃ |
|
Ясность из решение | Clear and colourless |
Хлорид | ≤0.014% |
Тяжелый металлы | ≤10 ppm |
Мышьяк | ≤22ppm |
Readily carbonizable substances | NO colour develops |
Cis-Isomer | ≤0.8% |
Потеря вкл . сушка | ≤0.5% |
Остаток вкл . ignition | ≤0.10% |
Анализ | ≥99,0% C₈h1sno₂ (высушенный) |
Транексамовая кислота - синтетическое производное лизина, которое является антифибринолитическим препаратом и обладает кровоостанавливающими свойствами
Гемостатические средства оказывают значительное влияние на травматическое кровотечение, а профилактическое медикаментозное лечение перед операцией может уменьшить хирургическое кровотечение
25 кг/ барабан, 9 тонн /20 ' контейнер
25 кг/мешок, 20 тонн /20 ' контейнер